Join Dr. Pasieka as she chats with Drs. Shaha & Urken about navigating unexpected tracheal invasion in thyroid cancer surgery. Tune in to "Surgeons vs. the Unexpected"! ๐ง๐ https://t.co/St74fenoXZ #CancerCare#SpotifyPodcast#ApplePodcast#AudiblePodcast#PodChaser
How far can surgery be safely de-escalated in MTC? Part 2 w/Dr. Lorenz explores frozen section guidance, staged approaches and neoadjuvant RET therapy ๐ง https://t.co/St74fenoXZ
#MTC#RETInhibitors
Who is the right surgical candidate for medullary thyroid carcinoma? This 2-Part episode explores calcitonin, imaging and genetic timing with Dr. Kerstin Lorenz. ๐ง https://t.co/St74fenoXZ
#MTC#EndocrineSurgery
New Voices of Wisdom: Dr. Zubair Baloch shares thyroid FNA pearls, what โadequateโ really means, and where molecular testing and AI can help. https://t.co/St74fenoXZ #ThyroidCytology#ThyroidCancer
Warm stories, meaningful moments,and holiday-inspired recipes come together in this uplifting webinar. A reminder that connection and community matterโฆ especially this time of year โ๏ธ https://t.co/uRZPKvlOV2
#HolidayWebinar#CancerSupport
Our expert-led tumor board brought together leaders in thyroid imaging, pathology, surgery, & endocrine careโmoderated by Dr. Tuttle. Watch the full session ๐ https://t.co/7kbuCtASDu #TIROxMDS#ThyroidCare
๐ฃ Calling all thyroid specialists!
Join us this Friday for TIRO x MDS โ featuring a deep dive into โManagement of Follicular Thyroid Carcinoma.โ
This review brings fresh clarity to one of our toughest challenges: how to refine diagnosis, surgical decisions, and prognostic stratification when FTC so closely mimics benign disease.
๐๏ธ Presenter: Dr. Haruhiko Yamazaki
๐ฌ Discussant: Dr. David Pattison
๐งญ Moderator: Dr. Eyal Robenshtok
๐๏ธ Friday, November 21
โฐ 8:00 AM EST
๐ Zoom: https://t.co/7XbgMFP8BG
A great session to update your FTC approach and compare perspectives with global experts.
See you there! ๐
Our recent #TIROxMDS session featured Dr. Carla Gambale, who reviewed evidence on when a second I-131 treatment benefits patients with biochemical persistent DTC. Watch the full discussion ๐ https://t.co/2sky5Nw2kl #ThyroidCancer
How effective is active surveillance for low-risk papillary thyroid carcinoma? ๐ฉบ Dr. Sugitani is joined by Dr. Tuttle to explore long-term outcomes and evolving management approaches. Watch now ๐ https://t.co/61BhCsDxnd #TIROxMDS#ThyroidCancer
Dr. Alessandro Prete joined #TIROxMDS to discuss how the International Grading System improves care for sporadic medullary thyroid carcinoma. A valuable session for thyroid specialists! ๐ https://t.co/1sFmYwnaVf
We hosted Dr. Jonathon Russell for a powerful TIROxMDS session on the 2024 Consensus for Ultrasound-Guided Thermal Ablation in Papillary Thyroid Carcinoma! Watch now ๐ https://t.co/705CZ6Id4b #TIROxMDS#ThyroidCare
Dr. Yasuhiro Ito joined #TIROxMDS to explore how pre-, intra- & post-operative findings impact outcomes in papillary & follicular #ThyroidCancer Watch the recording ๐ https://t.co/FQ40aoZTt3
Our #TIROxMDS Journal Club featured Dr. Antonio Matrone on the 2022 ETA Consensus for post-surgical radioiodine therapy in differentiated thyroid cancer. Watch the recording ๐ https://t.co/NeJWHHfpqS #ThyroidCancer
The TIROxMDS panel brought leading experts together for a deep dive into thyroid cancer casesโmoderated by Dr. Michael Tuttle with cases from Dr. Shonka. Watch the recording now ๐ https://t.co/V0Hwogn84Q #TIROxMDS#Oncology
Check out our TIROxMDS webinar from Jan 20thโฆ Clinical Application of Next-Generation Sequencing with Drs. Krzyzanowska & Ma https://t.co/ZfxlUH4qRX
Dr. Teresa Ramone presented on molecular profiling of low-risk papillary thyroid carcinoma, joined by Dr. Allen Ho. Catch this expert discussion in our past #TIROxMDS session ๐ https://t.co/bpX4ZuoEJB #Oncology